Palladium-α-lipoic acid complex attenuates alloxan-induced hyperglycemia and enhances the declined blood antioxidant status in diabetic rats

Journal of Diabetes

Volumn 3, Issue 4, 2011, Pages 293-300

  Sudheesh, Narayana P ^a   Ajith, Thekuttuparambil A ^b   Janardhanan, Kainoor K ^a   Krishnan, Chirakkal V ^c,d  

^a AMALA CANCER RESEARCH CENTRE   (India)

^b AMALA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Garnett McKeen Laboratory   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

Antioxidant; Diabetes mellitus; Palladium lipoic acid complex; Reactive oxygen species

Indexed keywords

ALLOXAN; ANTIOXIDANT; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; PALLADIUM COMPLEX; PALLADIUM THIOCTIC ACID COMPLEX; SCAVENGER; SUPEROXIDE DISMUTASE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; IN VITRO STUDY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; SCAVENGING SYSTEM;

ALLOXAN; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALE; PALLADIUM; RATS; RATS, INBRED STRAINS; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

EID: 82355191965     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2011.00142.x     Document Type: Article

References (32)

1. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol. 2003; 17: 24-38.
2. Palanduz S, Ademoglu E, Gokkusu C, Tamer S. Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol. 2001; 109: 309-18.
3. Kristal BS, Matsuda M, Yu BP. Abnormalities in the mitochondrial permeability transition in diabetic rats. Biochem Biophys Res Commun. 1996; 222: 519-23.
4. Gao E, Liu C, Zhu M, Lin H, Wu Q, Liu L. Current development of Pd(II) complexes as potential antitumor agents. Anticancer Agents Med Chem. 2009; 9: 356-68.
5. Caires ACF. Recent advances involving palladium (II) complexes for the cancer therapy. Anticancer Agents Med Chem. 2007; 7: 484-91.
6. Antonawich FJ, Fiore SM, Welicky LM. Regulation of ischemic cell death by the lipoic acid-palladium complex, Poly-MVA, in gerbils. Exp Neurol. 2004; 189: 10-5.
7. Sudheesh NP, Ajith TA, Janardhanan KK, Krishnan CV. Palladium α-lipoic acid complex formulation enhances activities of Krebs cycle dehydrogenases and respiratory complexes I-IV in the heart of aged rats. Food Chem Toxicol. 2009; 47: 2124-8.
8. Sudheesh NP, Ajith TA, Janardhanan KK, Krishnan CV. Effect of Poly-MVA, a palladium α-lipoic acid complex formulation against declined mitochondrial antioxidant status in the myocardium of aged rats. Food Chem Toxicol. 2010; 48: 1858-62.
9. Estrada DE, Ewart HS, Tsakiridis T et al. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: Participation of elements of the insulin signaling pathway. Diabetes. 1996; 45: 1798-804.
10. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes. Diabetologia. 2000; 43: 294-303.
11. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol. 2005; 4: 5-12.
12. Ajith TA, Janardhanan KK. Phellinus rimosus protects carbon tetrachloride-induced chronic hepatotoxicity in rats: Antioxidant defense mechanism. Pharm Biol. 2006; 44: 467-74.
13. Miami M, Yoshikawa H. A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta. 1979; 92: 337-42.
14. McCord JM, Fridovich I. Superoxide dismutase, an enzymatic function for erythrocuprein. J Biol Chem. 1969; 244: 6049-55.
15. Aebi H. Catalase. Bergmeyer DU (ed.). Methods in Enzymatic Analysis. Academic Press, New York, 1974; 673-84.
16. Paglia DE, Valentine WNJ. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70: 158-69.
17. Moron MA, Depierre JW, Mannervik B. Levels of glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979; 582: 67-78.
18. Aquino R, Morelli S, Lauro MR, Abdo S, Saija A, Tomaino A. Phenolic constituents and antioxidant activity of an extract of Anthurium versicular leaves. J Nat Prod. 2001; 64: 1019-23.
19. Ohkawa H, Oshishi N, Yagi K. Assay for lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-8.
20. Elizabeth S, Rao MNA. Oxygen radical scavenging activity of curcumin. Int J Pharm. 1990; 58: 237-40.
21. Anne J, Markus T, Siguard L. Effect of superoxide dismutase, catalase, chelating agents and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro. Free Radic Biol Med. 1999; 26: 1300-4.
22. Ho E, Chen G, Bray T. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NF-κB activation offering protection against chemically induced diabetes. Free Radic Biol Med. 2000; 4: 604-14.
23. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005; 7: 1040-52.
24. Kaneto H, Kawamori D, Matsuoka TA, Kajimoto Y, Yamasaki Y. Oxidative stress and pancreatic beta-cell dysfunction. Am J Ther. 2005; 12: 529-33.
25. Garnett M. Palladium complexes and methods for using same in the treatment of psoriasis. (US) patent no. 5, 776, 973. 7 July 1998.
26. Garnett M. Palladium complexes and methods for using same in the treatment of tumors. (US) patent no. 5, 679, 697. 21 October 1997.
27. Krishnan CV, Garnett M. Liquid crystal behavior in solutions, electrode passivation, and impedance loci in four quadrants. Marcus P, Maurice V (eds). Passivation of Metals and Semiconductors, and Properties of Thin Oxide Layers. Elsevier, Amsterdam, 2006; 389-94.
28. Brignone JA, de Brignone CM, de Mignone IR, Ricci CR, Susemihl MC, Rodriguez RR. Improving effects obtained by the ovariectomy or treatment with tamoxifen of female diabetic rats over the function and enzyme activities of liver mitochondria. Horm Metab Res. 1991; 23: 56-61.
29. Ceriello A. Oxidative stress, insulin resistance and cardiovascular disease. Byrne CD, Wild SH (eds). The Metabolic Syndrome. John Wiley & Sons, Chichester, 2006; 189-205.
30. Shen CC, Huang HM, Ou HC, Chen HL, Chen WC, Jeng KC. Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenation. J Biomed Sci. 2004; 11: 472-81.
31. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetes beta- cells. Nature. 2001; 414: 807-12.
32. Li CJ, Zhang QM, Li MZ, Zhang JY, Yu P, Yu DM. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. Chin Med J (Engl). 2009; 122: 2580-6.